Is there a Lao generic version of Entrectinib?

Entrectinib generic drugs are mainly Laotian generic drugs. The price is around 4,000~8,000 yuan, which is much cheaper than the original drug. The ingredients of the original drug and the generic drug are basically the same. Entrectinib has been launched in China, but due to its short time on the market, it has not yet been included in the medical insurance catalog. Since it has just been launched, it is difficult to purchase domestically and the price is very high. For specific prices, please consult the hospital pharmacy at that time. There are original drugs and generic drugs abroad. The original drugs abroad are mainly European versions of original drugs. The price is about 45,000 yuan. The price is relatively high and may be unaffordable for ordinary families.

Enrectinib has shown significant efficacy in ROS1 fusion-positive non-small cell lung cancer patients. This gene fusion is common in some NSCLC patients, and traditional treatments are often not effective enough. Entrectinib can prevent the growth and spread of tumor cells by inhibiting the activity of ROS1 fusion protein, thereby helping patients achieve better therapeutic effects.

TRK fusions are found in a variety of cancers, including lung cancer. Entrectinib can inhibit the activity of TRK fusion proteins and has a therapeutic effect on these gene fusion-positive tumors. TRKFusions are generally rare, but entrectinib still has therapeutic potential in these patients.

Enrectinib also showed good efficacy in patients with ALK fusion-positive non-small cell lung cancer. Clinical trial data show that entrectinib can effectively inhibit the ALK fusion protein and slow down the growth of tumors.

In addition to lung cancer, entrectinib may also be used to treat other solid tumors, such as neuroblastoma (neuroblastoma), lymphoma (lymphoma) etc. This depends on the patient's genotype and tumor characteristics.